Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2017-09-06 Notice of Dividend Amou…
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
2017年半年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an announcement regarding the implementation of the 2017 semi-annual dividend distribution by Zhengzhou Antu Bioengineering Co., Ltd. It details the dividend per share, relevant dates for dividend distribution, tax withholding policies, and the shareholder meeting approval date. The content focuses on dividend amount, payment dates, and procedures for distribution rather than presenting financial statements or comprehensive financial performance data. The document length is 2159 characters, which is relatively short and consistent with a dividend announcement rather than a full report. Therefore, this document fits the category of Notice of Dividend Amount (DIV).
2017-09-06 Chinese
关于持股5%以上的股东减持后持股比例低于5%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a shareholder's reduction in holdings below the 5% threshold. It details the shareholder's name, number of shares reduced, dates, and percentages before and after the reduction. It explicitly states that the shareholder's holding fell below 5%, and references a related simplified equity change report. This matches the definition of a Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds. The document is short and focused solely on shareholding changes, not a full financial report or other types of filings.
2017-09-05 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding by TOPPING DRAGON INVESTMENT LIMITED in 郑州安图生物工程股份有限公司 (Zhengzhou Antu Bioengineering Co., Ltd.). The content includes specifics about the number of shares held before and after the transaction, the method of share reduction (block trade), dates of transactions, and the percentage of shares held. It also references relevant securities laws and regulations governing disclosure of shareholding changes. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of a change in major shareholding, consistent with disclosures required when a shareholder crosses certain ownership thresholds or changes their stake significantly. Therefore, the document fits the category of Major Shareholding Notification (MRQ). The document length (5998 characters) and detailed content support this classification with high confidence.
2017-09-05 Chinese
使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Zhengzhou Antu Bioengineering Co., Ltd. regarding the progress of cash management using idle funds. It details the company's purchase and redemption of various financial products such as open-ended wealth management products, structured deposits, and fixed deposits. The document includes specific transaction dates, amounts, and yields, but it is essentially an update on the company's financing activities related to cash management. It does not contain comprehensive financial statements or detailed financial performance data typical of an interim or annual report. It is not a report publication announcement since it contains substantive information rather than just a notice. The content aligns with updates on company fundraising, financing activities, or capital structure changes, which fits the Capital/Financing Update (CAP) category.
2017-09-04 Chinese
使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhengzhou Antu Bioengineering Co., Ltd. regarding the progress of cash management using idle raised funds. It details contracts signed for financial products, amounts invested, returns, and ongoing financial product purchases. The document is relatively short (1811 characters) and focuses on updates about the use of idle raised funds for cash management, including specific financial product contracts and returns. It does not contain comprehensive financial statements or detailed financial performance data typical of an Annual Report (10-K) or Interim Report (IR). It is not a certification or officer attestation. The document is an update announcement about financing activities related to the use of raised funds, which fits the category of Capital/Financing Update (CAP).
2017-09-04 Chinese
关于控股子公司完成工商注册登记并取得营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Zhengzhou Antu Bioengineering Co., Ltd. regarding the completion of business registration and obtaining a business license for a newly established subsidiary company. It includes details such as the company name, registration number, legal representative, registered capital, and business scope. There is no financial data, no mention of financial results, no regulatory certifications, or voting results. It is not a report or a financial filing but a corporate announcement about a subsidiary's registration. This fits best under Regulatory Filings (RNS) as a general corporate announcement that does not fit other specific categories.
2017-09-04 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.